Affron (R) and increase in positive mood: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 - Université de Lille Accéder directement au contenu
Article Dans Une Revue EFSA Journal Année : 2021

Affron (R) and increase in positive mood: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006

S. de Henauw
  • Fonction : Auteur
K. I. Hirsch-Ernst
  • Fonction : Auteur
J. Kearney
  • Fonction : Auteur
H. K. Knutsen
  • Fonction : Auteur
A. Maciuk
  • Fonction : Auteur
I. Mangelsdorf
  • Fonction : Auteur
H. J. Mcardle
  • Fonction : Auteur
A. Naska
  • Fonction : Auteur
C. Pelaez
  • Fonction : Auteur
K. Pentieva
  • Fonction : Auteur
F. Thies
  • Fonction : Auteur
S. Tsabouri
  • Fonction : Auteur
M. Vinceti
  • Fonction : Auteur
J. L. Bresson
  • Fonction : Auteur
A. Siani
  • Fonction : Auteur

Résumé

Following an application from Pharmactive Biotech Products, S.L. submitted for authorisation of ahealth claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority ofSpain, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver anopinion on the scientific substantiation of a health claim related to affron®and contributes to maintaina healthy mood. The scope of the application was proposed to fall under a health claim based onnewly developed scientific evidence. The food proposed by the applicant as the subject of the healthclaim is affron®, an aqueous saffron extract with a content of the sum of crocins and safranal typicallybetween 3.5% and 3.9%. The Panel notes that affron®is sufficiently characterised. The claimed effectproposed by the applicant is‘contributes to maintain a healthy mood’. The Panel notes that increase inpositive mood is a beneficial physiological effect for individuals with low mood or anxiety. One humanintervention study showed that consumption of affron®at a dose of 28 mg/day for 4 weeks improvesmood in a population of adults with low mood. However, the results have not been replicated in otherstudies. The information supplied by the applicant did not provide evidence for a plausible mechanismby which affron®could exert the claimed effect. The Panel concludes that the evidence is insufficientto establish a cause and effect relationship between the consumption of affron®and increase inpositive mood.
Fichier principal
Vignette du fichier
EFSA Journal - 2021 - - Affron and increase in positive mood evaluation of a health claim pursuant to Article 13 5 of.pdf (1.48 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-04482009 , version 1 (28-02-2024)

Licence

Identifiants

Citer

Dominique Turck, J. Castenmiller, S. de Henauw, K. I. Hirsch-Ernst, J. Kearney, et al.. Affron (R) and increase in positive mood: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006. EFSA Journal, 2021, EFSA Journal, 19, ⟨10.2903/j.efsa.2021.6669⟩. ⟨hal-04482009⟩

Collections

RIIP UNIV-LILLE
6 Consultations
5 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More